$3.74 Billion is the total value of Perceptive Advisors's 117 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 49.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $587,363,000 | +26.8% | 4,777,254 | +1.3% | 15.71% | +29.3% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $250,196,000 | -20.0% | 20,694,424 | +3.3% | 6.69% | -18.4% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $195,658,000 | -10.4% | 5,148,910 | +6.6% | 5.23% | -8.6% |
| ZGNX | Sell | ZOGENIX INC | $188,858,000 | +7.6% | 3,807,632 | -4.1% | 5.05% | +9.8% |
| SOLID BIOSCIENCES INC | $185,286,000 | +32.4% | 3,927,222 | 0.0% | 4.95% | +35.1% | ||
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $104,848,000 | -42.4% | 1,197,994 | -35.1% | 2.80% | -41.2% |
| XLRN | ACCELERON PHARMA INC | $87,459,000 | +18.0% | 1,528,205 | 0.0% | 2.34% | +20.3% | |
| LJPC | LA JOLLA PHARMACEUTICAL CO | $86,833,000 | -31.0% | 4,313,611 | 0.0% | 2.32% | -29.6% | |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $82,014,000 | +9.5% | 7,290,199 | +24.6% | 2.19% | +11.7% |
| ASND | ASCENDIS PHARMA A Ssponsored adr | $76,008,000 | +6.5% | 1,072,647 | 0.0% | 2.03% | +8.6% | |
| CRNX | New | CRINETICS PHARMACEUTICALS INC | $74,144,000 | – | 2,587,953 | +100.0% | 1.98% | – |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $73,466,000 | +20.4% | 941,147 | -2.1% | 1.96% | +22.8% |
| MYOK | MYOKARDIA INC | $71,014,000 | +31.3% | 1,089,169 | 0.0% | 1.90% | +33.9% | |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $67,604,000 | +66.2% | 3,009,998 | +42.8% | 1.81% | +69.6% |
| QTNT | Buy | QUOTIENT LTD | $66,357,000 | +27.5% | 8,789,054 | +35.6% | 1.77% | +30.0% |
| DOVA | DOVA PHARMACEUTICALS INC | $65,549,000 | -29.9% | 3,125,851 | 0.0% | 1.75% | -28.5% | |
| MGTX | MEIRAGTX HOLDINGS PLC | $63,966,000 | +18.7% | 4,703,398 | 0.0% | 1.71% | +21.0% | |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $62,908,000 | +71.4% | 1,366,978 | +62.4% | 1.68% | +74.8% |
| MMSI | Sell | MERIT MED SYS INC | $61,093,000 | +10.3% | 994,198 | -8.1% | 1.63% | +12.5% |
| RTRX | RETROPHIN INC | $60,483,000 | +5.4% | 3,212,871 | 0.0% | 1.62% | +7.5% | |
| CORI | CORIUM INTERNATIONAL INC | $60,456,000 | +18.7% | 6,357,133 | 0.0% | 1.62% | +21.1% | |
| ALBO | ALBIREO PHARMA INC | $56,175,000 | -7.2% | 1,704,330 | 0.0% | 1.50% | -5.3% | |
| VRCA | VERRICA PHARMACEUTICALS INC | $55,419,000 | -17.6% | 3,410,412 | 0.0% | 1.48% | -16.0% | |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $49,242,000 | +12.1% | 2,661,715 | +38.5% | 1.32% | +14.3% |
| ATNX | Buy | ATHENEX INC | $44,592,000 | +1157.9% | 2,869,528 | +1410.3% | 1.19% | +1181.7% |
| KDMN | KADMON HLDGS INC | $43,973,000 | -16.3% | 13,165,746 | 0.0% | 1.18% | -14.6% | |
| ECYT | Buy | ENDOCYTE INC REGISTERED SHS | $43,365,000 | +63.5% | 2,441,700 | +27.1% | 1.16% | +66.9% |
| ALDX | ALDEYRA THERAPEUTICS INC | $42,579,000 | +73.6% | 3,085,458 | 0.0% | 1.14% | +77.1% | |
| ARGX | Buy | ARGENX SEsponsored adr | $42,541,000 | -3.0% | 560,941 | +5.9% | 1.14% | -1.0% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $41,615,000 | -13.0% | 72,500 | -27.5% | 1.11% | -11.2% |
| ADMA | ADMA BIOLOGICS INC | $40,496,000 | +37.7% | 6,521,102 | 0.0% | 1.08% | +40.5% | |
| BHVN | Sell | BIOHAVEN PHARMACEUTICAL HLDG CO L | $37,210,000 | -65.7% | 990,943 | -63.9% | 1.00% | -65.0% |
| RGNX | Sell | REGENXBIO INC | $35,536,000 | -42.9% | 470,672 | -45.7% | 0.95% | -41.8% |
| QURE | Sell | UNIQURE NV | $35,402,000 | -35.2% | 972,831 | -32.7% | 0.95% | -33.9% |
| VRAY | Buy | VIEWRAY INC REGISTERED SHS | $34,632,000 | +6572.8% | 3,700,000 | +4833.3% | 0.93% | +6514.3% |
| NEPT | New | NEPTUNE WELLNESS SOLUTIONS I | $34,498,000 | – | 8,891,452 | +100.0% | 0.92% | – |
| XNCR | Sell | XENCOR INC | $32,271,000 | -18.4% | 828,095 | -22.5% | 0.86% | -16.7% |
| NVTA | Sell | INVITAE CORP | $31,136,000 | +109.6% | 1,861,100 | -7.9% | 0.83% | +114.1% |
| CBAY | CYMABAY THERAPEUTICS INC | $30,390,000 | -17.4% | 2,742,821 | 0.0% | 0.81% | -15.8% | |
| VBIV | VBI VACCINES INC REGISTERED SHS | $23,391,000 | -12.0% | 9,665,843 | 0.0% | 0.62% | -10.3% | |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $21,629,000 | -2.2% | 2,449,521 | +10.6% | 0.58% | -0.3% |
| AQST | New | AQUESTIVE THERAPEUTICS INC | $20,137,000 | – | 1,150,000 | +100.0% | 0.54% | – |
| RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $19,374,000 | -22.6% | 664,186 | -17.0% | 0.52% | -21.0% |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $17,806,000 | +218.1% | 3,107,424 | +178.1% | 0.48% | +223.8% |
| ZYME | ZYMEWORKS INC | $16,911,000 | +6.2% | 1,123,890 | 0.0% | 0.45% | +8.4% | |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $15,992,000 | -36.0% | 168,939 | -45.2% | 0.43% | -34.7% |
| ESTA | New | ESTABLISHMENT LABS HLDGS INC | $15,304,000 | – | 635,000 | +100.0% | 0.41% | – |
| PRQR | New | PROQR THERAPEUTICS N.V. | $14,725,000 | – | 761,000 | +100.0% | 0.39% | – |
| MOTS | MOTUS GI HOLDINGS INC REGISTERED SHS | $14,333,000 | -29.1% | 2,810,542 | 0.0% | 0.38% | -27.7% | |
| LIVN | New | LIVANOVA PLC | $13,761,000 | – | 111,000 | +100.0% | 0.37% | – |
| SYBX | SYNLOGIC INC | $13,398,000 | +44.6% | 942,852 | 0.0% | 0.36% | +47.3% | |
| HUM | Sell | HUMANA INC | $11,848,000 | -73.1% | 35,000 | -76.4% | 0.32% | -72.6% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $11,700,000 | +8.2% | 234,019 | -17.2% | 0.31% | +10.2% |
| New | PROTAGONIST THERAPEUTICS INC | $10,973,000 | – | 1,066,415 | +100.0% | 0.29% | – | |
| ABMD | Sell | ABIOMED INC | $10,704,000 | -28.6% | 23,800 | -35.1% | 0.29% | -27.2% |
| MTEM | Buy | MOLECULAR TEMPLATES INC | $10,641,000 | +181.0% | 1,974,133 | +172.6% | 0.28% | +187.9% |
| AMRN | New | AMARIN CORP PLCspons adr new | $9,928,000 | – | 610,200 | +100.0% | 0.26% | – |
| TXMD | New | THERAPEUTICSMD INC | $9,840,000 | – | 1,500,000 | +100.0% | 0.26% | – |
| MRNS | MARINUS PHARMACEUTICALS INC | $9,077,000 | +41.5% | 907,732 | 0.0% | 0.24% | +44.6% | |
| ADMS | Sell | ADAMAS PHARMACEUTICALS INC | $8,449,000 | -69.8% | 422,015 | -61.1% | 0.23% | -69.2% |
| ANI PHARMACEUTICALS INCnote 3.000%12/0 | $7,942,000 | -6.1% | 7,500,000 | 0.0% | 0.21% | -4.5% | ||
| TSRO | Buy | TESARO INC | $7,802,000 | +75.4% | 200,000 | +100.0% | 0.21% | +78.6% |
| CDNA | Sell | CAREDX INC | $7,521,000 | +31.4% | 260,676 | -44.3% | 0.20% | +34.0% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $7,006,000 | +41.0% | 365,445 | 0.0% | 0.19% | +43.8% | |
| EIDX | EIDOS THERAPEUTICS INC | $6,855,000 | -50.9% | 686,922 | 0.0% | 0.18% | -50.0% | |
| PTE | New | POLARITYTE INC | $6,433,000 | – | 336,818 | +100.0% | 0.17% | – |
| EHTH | New | EHEALTH INC | $6,393,000 | – | 226,220 | +100.0% | 0.17% | – |
| OMED | ONCOMED PHARMACEUTICALS INC | $5,556,000 | -8.2% | 2,620,897 | 0.0% | 0.15% | -6.3% | |
| UROV | New | UROVANT SCIENCES LTD | $5,552,000 | – | 462,659 | +100.0% | 0.15% | – |
| SRRA | Sell | SIERRA ONCOLOGY INC | $5,440,000 | -59.2% | 3,200,000 | -28.9% | 0.14% | -58.5% |
| ABEOW | Sell | ABEONA THERAPEUTICS INCw exp 12/24/201 | $5,145,000 | -59.8% | 659,636 | -47.6% | 0.14% | -58.9% |
| TBIO | TRANSLATE BIO INC | $5,000,000 | -20.9% | 500,000 | 0.0% | 0.13% | -19.3% | |
| CLVS | New | CLOVIS ONCOLOGY INC | $4,406,000 | – | 150,000 | +100.0% | 0.12% | – |
| STIM | Buy | NEURONETICS INC | $4,345,000 | +30.1% | 135,500 | +8.0% | 0.12% | +31.8% |
| GERN | New | GERON CORPput | $3,680,000 | – | 1,950,000 | +100.0% | 0.10% | – |
| ACHN | ACHILLION PHARMACEUTICALS IN | $3,680,000 | +30.0% | 1,000,000 | 0.0% | 0.10% | +32.4% | |
| XERS | Sell | XERIS PHARMACEUTICALS INC | $3,527,000 | -58.7% | 200,627 | -55.4% | 0.09% | -58.0% |
| EVH | Buy | EVOLENT HEALTH INCcl a | $3,124,000 | +111.9% | 110,000 | +57.1% | 0.08% | +115.4% |
| ABEO | Buy | ABEONA THERAPEUTICS INC | $3,078,000 | +222.6% | 240,459 | +303.0% | 0.08% | +228.0% |
| NVTRQ | Sell | NUVECTRA CORP | $2,967,000 | -9.4% | 135,000 | -15.3% | 0.08% | -8.1% |
| IVC | INVACARE CORP | $2,910,000 | -21.8% | 200,000 | 0.0% | 0.08% | -20.4% | |
| ALNA | ALLENA PHARMACEUTICALS INC | $2,685,000 | -17.6% | 250,000 | 0.0% | 0.07% | -15.3% | |
| ARVN | New | ARVINAS INC | $2,109,000 | – | 125,000 | +100.0% | 0.06% | – |
| VERU | New | VERU INC | $2,024,000 | – | 1,425,000 | +100.0% | 0.05% | – |
| ODT | Sell | ODONATE THERAPEUTICS INC | $1,941,000 | -41.4% | 100,000 | -33.3% | 0.05% | -40.2% |
| EIGR | EIGER BIOPHARMACEUTICALS INC REGISTERED SHS | $1,892,000 | -1.6% | 157,679 | 0.0% | 0.05% | +2.0% | |
| KNSA | Sell | KINIKSA PHARMACEUTICALS LTD | $1,356,000 | -29.7% | 53,169 | -52.1% | 0.04% | -29.4% |
| TRHC | TABULA RASA HEALTHCARE INC | $1,190,000 | +27.1% | 14,663 | 0.0% | 0.03% | +28.0% | |
| VKTX | New | VIKING THERAPEUTICS INC | $1,119,000 | – | 64,261 | +100.0% | 0.03% | – |
| FCAU | FIAT CHRYSLER AUTOMOBILES N. | $1,086,000 | -7.3% | 62,000 | 0.0% | 0.03% | -6.5% | |
| BGNE | BEIGENE LTDsponsored adr | $982,000 | +12.1% | 5,700 | 0.0% | 0.03% | +13.0% | |
| ALQA | ALLIQUA BIOMEDICAL INC | $961,000 | +10.8% | 423,394 | 0.0% | 0.03% | +13.0% | |
| CSU | CAPITAL SR LIVING CORP | $946,000 | -11.5% | 100,173 | 0.0% | 0.02% | -10.7% | |
| PTCT | PTC THERAPEUTICS INC | $910,000 | +39.4% | 19,367 | 0.0% | 0.02% | +41.2% | |
| RACE | FERRARI N.V. | $849,000 | +1.4% | 6,200 | 0.0% | 0.02% | +4.5% | |
| RETA | New | REATA PHARMACEUTICALS INC | $791,000 | – | 9,677 | +100.0% | 0.02% | – |
| GTHX | G1 THERAPEUTICS INC | $735,000 | +20.3% | 14,055 | 0.0% | 0.02% | +25.0% | |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $711,000 | – | 5,627 | +100.0% | 0.02% | – |
| HSGX | Sell | HISTOGENICS CORP | $656,000 | -88.1% | 1,203,399 | -45.4% | 0.02% | -87.5% |
| MNTA | MOMENTA PHARMACEUTICALS INC | $644,000 | +28.5% | 24,489 | 0.0% | 0.02% | +30.8% | |
| NTRA | New | NATERA INC | $575,000 | – | 24,000 | +100.0% | 0.02% | – |
| SENS | SENSEONICS HLDGS INC | $549,000 | +16.1% | 115,000 | 0.0% | 0.02% | +25.0% | |
| BLFS | New | BIOLIFE SOLUTIONS INC | $514,000 | – | 29,376 | +100.0% | 0.01% | – |
| PRTO | Sell | PROTEON THERAPEUTICS INC | $469,000 | -42.7% | 240,488 | -28.0% | 0.01% | -38.1% |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $474,000 | -94.7% | 2,213 | -93.1% | 0.01% | -94.5% |
| ADMP | New | ADAMIS PHARMACEUTICALS CORP | $481,000 | – | 137,500 | +100.0% | 0.01% | – |
| IMMU | New | IMMUNOMEDICS INC | $444,000 | – | 21,335 | +100.0% | 0.01% | – |
| PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0 | $413,000 | -3.1% | 1,000,000 | 0.0% | 0.01% | 0.0% | ||
| VCNX | New | VACCINEX INC | $365,000 | – | 50,000 | +100.0% | 0.01% | – |
| VCEL | VERICEL CORP | $385,000 | +45.8% | 27,211 | 0.0% | 0.01% | +42.9% | |
| HCM | HUTCHISON CHINA MEDITECH LTDsponsored adr | $322,000 | +7.0% | 10,000 | 0.0% | 0.01% | +12.5% | |
| CASI | CASI PHARMACEUTICALS INC | $204,000 | -43.3% | 43,682 | 0.0% | 0.01% | -44.4% | |
| ONCS | ONCOSEC MED INC | $70,000 | +1.4% | 50,000 | 0.0% | 0.00% | 0.0% | |
| New | SOLID BIOSCIENCES INCcall | $40,000 | – | 1,835 | +100.0% | 0.00% | – | |
| GERN | New | GERON CORPcall | $10,000 | – | 200,000 | +100.0% | 0.00% | – |
| ONSIW | New | ONCOBIOLOGICS INC*w exp 02/18/201 | $6,000 | – | 420,875 | +100.0% | 0.00% | – |
| CAPR | CAPRICOR THERAPEUTICS INC | $4,000 | -20.0% | 4,000 | 0.0% | 0.00% | – | |
| ELOX | Exit | ELLOX PHARMACEUTICALS INC | $0 | – | -2,961 | -100.0% | -0.00% | – |
| ACST | Exit | ACASTI PHARMA INCcl a new | $0 | – | -206,677 | -100.0% | -0.00% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.01% | – |
| AGLE | Exit | AEGLEA BIOTHERAPEUTICS INC | $0 | – | -25,694 | -100.0% | -0.01% | – |
| VRNA | Exit | VERONA PHARMA PLCsponsored adr | $0 | – | -22,327 | -100.0% | -0.01% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -6,057 | -100.0% | -0.01% | – |
| SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -0.01% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -80,845 | -100.0% | -0.01% | – |
| VTL | Exit | VITAL THERAPIES INC | $0 | – | -150,000 | -100.0% | -0.01% | – |
| COLL | Exit | COLLEGIUM PHARMACEUTICAL INC | $0 | – | -24,213 | -100.0% | -0.02% | – |
| ADAP | Exit | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $0 | – | -49,302 | -100.0% | -0.02% | – |
| LOXO | Exit | LOXO ONCOLOGY INC | $0 | – | -3,765 | -100.0% | -0.02% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -40,133 | -100.0% | -0.02% | – |
| AZRX | Exit | AZURRX BIOPHARMA INC | $0 | – | -227,272 | -100.0% | -0.02% | – |
| VICL | Exit | VICAL INC | $0 | – | -1,142,858 | -100.0% | -0.03% | – |
| SBBP | Exit | STRONGBRIDGE BIOPHARMA PLC | $0 | – | -275,000 | -100.0% | -0.04% | – |
| AGRX | Exit | AGILE THERAPEUTICS INC | $0 | – | -3,530,000 | -100.0% | -0.05% | – |
| Exit | CHAMPIONS ONCOLOGY INC | $0 | – | -366,972 | -100.0% | -0.06% | – | |
| GERN | Exit | GERON CORP | $0 | – | -2,550,000 | -100.0% | -0.08% | – |
| AVEO | Exit | AVEO PHARMACEUTICALS INC | $0 | – | -1,891,192 | -100.0% | -0.11% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -150,695 | -100.0% | -0.16% | – |
| CLSD | Exit | CLEARSIDE BIOMEDICAL INC | $0 | – | -707,581 | -100.0% | -0.20% | – |
| FLXN | Exit | FLEXION THERAPEUTICS INC | $0 | – | -307,989 | -100.0% | -0.21% | – |
| AXGN | Exit | AXOGEN INC | $0 | – | -165,000 | -100.0% | -0.22% | – |
| MNLO | Exit | MENLO THERAPEUTICS INC | $0 | – | -1,241,287 | -100.0% | -0.26% | – |
| TDOC | Exit | TELADOC INC | $0 | – | -195,000 | -100.0% | -0.30% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -75,898 | -100.0% | -0.34% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -150,875 | -100.0% | -0.36% | – |
| NEPT | Exit | NEPTUNE TECHNOLOGIES AND BIORESO | $0 | – | -8,574,015 | -100.0% | -0.53% | – |
| GTXI | Exit | GTX INC DEL | $0 | – | -1,501,501 | -100.0% | -0.60% | – |
| ATHN | Exit | ATHENAHEALTH INC | $0 | – | -150,000 | -100.0% | -0.63% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -660,406 | -100.0% | -0.66% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -564,579 | -100.0% | -0.72% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -713,191 | -100.0% | -0.92% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -463,450 | -100.0% | -1.51% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.